Why Series A Health-Techs Lose 6 Months Trying to Hire Their First Sales Rep

I watched this happen at a digital therapeutics company in Boston.

They closed a $19M Series A in February. The new VP of Commercial started in April. By mid-May she had a job posting up for a senior enterprise sales rep with healthcare experience. First interview late June. Offer in early September. Rep started mid-October. First qualified meeting late November.

Eight months from Series A close to first qualified meeting.

That is not unusual. That is typical.

I have watched this pattern at roughly twenty Series A health-techs over the last few years. The variations are small. The outcome is the same. The company spends most of its first year of post-Series A runway hiring a sales rep who then needs another quarter to ramp before producing pipeline. By the time the rep is at full productivity, the company is twelve to fifteen months into the round and the Series B fundraise is six months out.

This is a runway problem dressed up as a hiring problem.

Walk through the timeline

Most VPs of Commercial running a sales search have never actually mapped the weeks. They should.

Twenty-eight weeks before you have any data. Six months before pipeline starts moving. Almost a full year before the first contract closes.

That is the math nobody runs before they start the search.

The part that gets ignored

The non-obvious problem is not the timeline. The non-obvious problem is what the founder is doing during those eight months.

Still running sales personally. Still taking the meetings. Still signing the contracts. Still managing every customer relationship.

Which means the commercial motion is still founder-dependent at month eight, exactly as it was at month one.

The rep that finally arrives in October walks into a pipeline the founder built and a customer base where every relationship runs through the founder. The rep then spends another three months trying to take over those relationships. Often unsuccessfully, because the customers signed on the strength of the founder's vision and they do not want to be handed off to someone they have never met.

I have watched three companies have to fire their first W2 hire and start over because of this. One did it twice.

A different sequence

The alternative is not "do not hire a W2 rep." The alternative is sequencing. (Priya wrote the longer treatment of W2 vs fractional vs contract if you want the comparison properly drawn out. I am going to stay focused on the timing here.)

If the new VP of Commercial places contract reps in two or three target territories in the first six weeks, those reps are producing meetings by week eight. The founder has someone to hand inbound to. The CRM starts capturing structured pipeline data. The board sees activity in the first quarter post-Series A. Not the third. (Marcus laid out the territory test mechanics at more length, if you want the full version.)

Then the W2 search runs in parallel. Not in serial.

By the time the W2 hire arrives in month seven, there is a working motion to plug them into. They are not building from zero. They are taking over a territory that already has 15 to 25 active opportunities.

The point is not that contract reps are always right. The point is sequencing. Running the W2 search and the contract field activity in parallel produces pipeline data while the search is happening. Running them in serial produces eight months of nothing.

The other failure I watch for

There is a second pattern. Less common but worth naming.

A VP of Commercial hires a W2 rep with the wrong specialty background and discovers it at month seven.

I watched a women's health digital platform hire a senior medical device rep last year. He had healthcare experience. Strong interview. Twelve years calling on hospital materials management. Zero relationships in OB-GYN practices.

By month eight he had produced four qualified meetings. All at the wrong buyer level. He was gone by month eleven.

Cost of that mis-hire: roughly $190K in salary and benefits. Plus eleven months. Plus the goodwill the company burned with the candidates it had passed on at the time.

Specialty fit matters more than general healthcare experience. Always. A rep who has called on cardiology practices for ten years will outperform a generalist with broad medical device experience in their first year, almost without exception. The contract rep model lets you test specialty fit in 90 days before you commit to a permanent hire. A W2 search does not give you that option.

Questions I push on before the search starts

When a VP of Commercial calls me three weeks into the role asking how to think about the first hire, I push on a few things before discussing tactics.

How much of the existing pipeline runs through the founder? If the answer is more than 70%, the first hire is not a sales rep. It is a transition plan for the founder's relationships. Hiring a W2 rep into that situation usually fails.

What is the buyer specialty mix? If the company sells into three different specialties, you cannot hire one rep with the right relationship base for all three. The contract approach lets you cover them in parallel.

What is the runway? If you have less than fifteen months, you do not have time to run a six-month W2 search and then wait three months for ramp. The sequencing has to be different.

What does the board expect at the next quarterly meeting? If the answer is "pipeline activity," contract reps produce that within six weeks. A W2 search does not produce that for six months.

These questions are not subtle. But they are usually not asked.

The math, summarized

The middle row is what most Series A health-techs should be doing. It is also what most are not doing, because they default to the W2 search out of habit. Not because they ran the math.